Tilray is a global leader in medical cannabis research and production dedicated to providing safe, consistent and reliable therapy to patients. We are the only GMP certified medical cannabis producer currently supplying products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers in Australia, Canada, the European Union and Latin America.
Tilray's experience is unmatched worldwide. Our team of 130+ professionals on the ground in 5 countries serves thousands of patients around the globe. Our $26 million cultivation facility is among the most advanced in the world.
Tilray is the only GMP certified medical cannabis producer in North America. All of our products are produced with meticulous care to ensure the highest quality, consistency and purity for our patients.
We are committed to scientific research that leads to an improved quality of life for patients in a time frame that matters. We are partnering with leading hospitals and universities to advance the clinical applications of cannabinoids.
Tilray takes tremendous pride in our customer service, patient outreach, and physician interaction. We recognize the importance of tracking potential adverse events as well as therapeutic benefits in order to ensure the safety of our patients.
PRODUCTS & STRAIN VARIETIES
Tilray cultivates a wide range of strains to meet patient needs including indicas, sativas, hybrids, and CBD-rich varieties. Medical cannabis is available in two primary forms: dried flower and extracts. Each can be administered or consumed via a variety of methods. Tilray is working closely with patients, physicians, and regulators to provide consistent availability of a range of compliant and effective forms of medical cannabis.
ADVANCING CANNABINOID SCIENCE
For the therapeutic value and risks of cannabinoid-based medicines to be fully understood, Tilray believes it is critical to evolve current scientific understanding of the field. Our clinical research program is designed with that in mind. We understand the importance of developing well-characterized, consistent preparations of specific cannabinoid compositions that meet regulatory agencies’ standards for use in clinical research.
Tilray choreographs a complex series of cutting-edge processes spanning fourteen weeks to deliver an unparalleled medical cannabis product to its patients. From cultivation to final shipping, Tilray's team brings precision, professionalism and care to each stage of the process.